We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) (ERIC)

This study has been terminated.
(Study terminated due to lack of resources.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01705509
First Posted: October 12, 2012
Last Update Posted: April 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Cardiovascular Institute of the South Clinical Research Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 31, 2017
  Primary Completion Date: March 31, 2017 (Final data collection date for primary outcome measure)